CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Dambkowski Carl Director | Option exercise · Stock Option (right to buy) 10b5-1 | −11,667 | 5,833 | ||
| 2026-05-18 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +2,000 | $12.50 | $25K | 20,863 |
| 2026-05-18 | Agarwal Arjun Senior Vice President, Finance | Option exercise 10b5-1 | +5,833 | $34.39 | $201K | 26,696 |
| 2026-05-18 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −4,190 | $58.34 | $244K | 22,506 |
| 2026-05-18 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −4,600 | $59.19 | $272K | 17,906 |
| 2026-05-18 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −800 | $60.34 | $48K | 17,106 |
| 2026-05-18 | Agarwal Arjun Senior Vice President, Finance | Sale 10b5-1 | −700 | $61.16 | $43K | 16,406 |
| 2026-05-18 | Agarwal Arjun Senior Vice President, Finance | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −2,000 | 118,000 | ||
| 2026-05-18 | Agarwal Arjun Senior Vice President, Finance | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,833 | 64,167 | ||
| 2026-05-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $6.84 | $24K | 36,877 |
| 2026-05-15 | Goncalves Joana Chief Medical Officer | Option exercise 10b5-1 | +3,500 | $7.80 | $27K | 40,377 |
| 2026-05-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −4,800 | $61.56 | $295K | 35,577 |
| 2026-05-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −2,100 | $62.42 | $131K | 33,477 |
| 2026-05-15 | Goncalves Joana Chief Medical Officer | Sale 10b5-1 | −100 | $63.52 | $6K | 33,377 |
| 2026-05-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −3,500 | 207,563 | ||
| 2026-05-15 | Goncalves Joana Chief Medical Officer | Option exercise · Employee Warrant (right to buy) 10b5-1 | −3,500 | 178,992 | ||
| 2026-05-01 | Sandler Laura Lee Chief Operating Officer | Option exercise 10b5-1 | +5,000 | $7.80 | $39K | 241,984 |
| 2026-05-01 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −2,200 | $62.58 | $138K | 239,784 |
| 2026-05-01 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −1,800 | $64.15 | $115K | 237,984 |
| 2026-05-01 | Sandler Laura Lee Chief Operating Officer | Sale 10b5-1 | −300 | $65.10 | $20K | 237,684 |
Page 10 of 18 · 346 trades